Skip to main content
Explore URMC

URMC Logo

URMC / Research / Research@URMC
Researchers Look to Improve Late-Stage Liver Cancer Therapy

Researchers Look to Improve Late-Stage Liver Cancer Therapy

Scientists discovered a potential therapy for late-stage liver cancer based on earlier work showing that the androgen receptor (AR), the protein that makes testosterone functional, plays a major role in regulating this type of malignancy. 

7/26/2016
Pancreatic Cancer Network Awards $2M to Wilmot Investigator

Pancreatic Cancer Network Awards $2M to Wilmot Investigator

The national Pancreatic Cancer Action Network (PANCAN) granted its most competitive award, for $2 million, to David C. Linehan, M.D., to support a large, multicenter clinical trial testing an immunotherapy in patients with metastatic pancreatic cancer.

7/13/2016
Is It Time for New Strategies to Treat Aggressive Prostate Cancer?

Is It Time for New Strategies to Treat Aggressive Prostate Cancer?

A new URMC study confirms that androgen deprivation therapy, which initially shrinks aggressive prostate tumors, is a double-edged sword that ultimately might fuel the spread of cancer.

4/27/2016
Authors Talk “Truth” in Tissue Samples

Authors Talk “Truth” in Tissue Samples

It’s incredible to think that years of scientific research might’ve been conducted with tissue samples that were nearly worthless—but that frustrating reality is what keeps David Hicks, M.D., and other progressive pathologists pushing for improvements.

3/23/2016
What Frogs Can Teach Us About Tumors

What Frogs Can Teach Us About Tumors

Researchers at the University of Rochester School of Medicine and Dentistry have developed a new model of cancer in frogs to study how tumors grow, spread, and manipulate immune cells. These scientists also coordinate the world’s largest resource for using these animals in research, which is housed at the University.

1/4/2016